These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. An updated Banff schema for diagnosis of antibody-mediated rejection in renal allografts. Haas M Curr Opin Organ Transplant; 2014 Jun; 19(3):315-22. PubMed ID: 24811440 [TBL] [Abstract][Full Text] [Related]
7. In the absence of natural killer cell activation donor-specific antibody mediates chronic, but not acute, kidney allograft rejection. Yagisawa T; Tanaka T; Miyairi S; Tanabe K; Dvorina N; Yokoyama WM; Valujskikh A; Baldwin WM; Fairchild RL Kidney Int; 2019 Feb; 95(2):350-362. PubMed ID: 30503624 [TBL] [Abstract][Full Text] [Related]
8. Pathology of C4d-negative antibody-mediated rejection in renal allografts. Haas M Curr Opin Organ Transplant; 2013 Jun; 18(3):319-26. PubMed ID: 23283250 [TBL] [Abstract][Full Text] [Related]
9. A case of chronic antibody-mediated rejection in the making. Bravou V; Galliford J; McLean A; Willicombe M; Taube D; Cook HT; Roufosse C Clin Nephrol; 2013 Oct; 80(4):306-9. PubMed ID: 22579273 [TBL] [Abstract][Full Text] [Related]
10. Memory CD4 T Cells Induce Antibody-Mediated Rejection of Renal Allografts. Gorbacheva V; Fan R; Fairchild RL; Baldwin WM; Valujskikh A J Am Soc Nephrol; 2016 Nov; 27(11):3299-3307. PubMed ID: 27020853 [TBL] [Abstract][Full Text] [Related]
11. C4d deposition in peritubular capillary and alloantibody in the allografted kidney suffering severe acute rejection. Abe M; Sawada T; Horita S; Toma H; Yamaguchi Y; Teraoka S Clin Transplant; 2003; 17 Suppl 10():14-9. PubMed ID: 12823251 [TBL] [Abstract][Full Text] [Related]
12. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. Mauiyyedi S; Crespo M; Collins AB; Schneeberger EE; Pascual MA; Saidman SL; Tolkoff-Rubin NE; Williams WW; Delmonico FL; Cosimi AB; Colvin RB J Am Soc Nephrol; 2002 Mar; 13(3):779-787. PubMed ID: 11856785 [TBL] [Abstract][Full Text] [Related]
13. Comparing transplant glomerulopathy in the absence of C4d deposition and donor-specific antibodies to chronic antibody-mediated rejection. Torres IB; Salcedo M; Moreso F; Sellarés J; Castellá E; Azancot MA; Perelló M; Cantarell C; Serón D Clin Transplant; 2014 Oct; 28(10):1148-54. PubMed ID: 25103874 [TBL] [Abstract][Full Text] [Related]
14. C4d deposition is correlated with the level of antivimentin antibody in rat kidneys undergoing chronic allograft nephropathy. Yang L; Lu YP; Luo GH; Song J; Tu ZD; Li YP Transplant Proc; 2008 Oct; 40(8):2786-9. PubMed ID: 18929862 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of C1q Status and Titer of De Novo Donor-Specific Antibodies as Predictors of Allograft Survival. Wiebe C; Gareau AJ; Pochinco D; Gibson IW; Ho J; Birk PE; Blydt-Hansen T; Karpinski M; Goldberg A; Storsley L; Rush DN; Nickerson PW Am J Transplant; 2017 Mar; 17(3):703-711. PubMed ID: 27539748 [TBL] [Abstract][Full Text] [Related]
16. The clinical and genomic significance of donor-specific antibody-positive/C4d-negative and donor-specific antibody-negative/C4d-negative transplant glomerulopathy. Hayde N; Bao Y; Pullman J; Ye B; Calder RB; Chung M; Schwartz D; Lubetzky M; Ajaimy M; de Boccardo G; Akalin E Clin J Am Soc Nephrol; 2013 Dec; 8(12):2141-8. PubMed ID: 24030736 [TBL] [Abstract][Full Text] [Related]
17. Association between C4d staining in renal transplant biopsies, production of donor-specific HLA antibodies, and graft outcome. Worthington JE; McEwen A; McWilliam LJ; Picton ML; Martin S Transplantation; 2007 Feb; 83(4):398-403. PubMed ID: 17318071 [TBL] [Abstract][Full Text] [Related]